N of 1 : One Man's Harvard-documented Remission of Incurable Cancer Using Only Natural Methods

Twenty-five years ago my doctors had no cure for my cancer. So I went on a quest to find my own treatment. This is my story...

In 1991, Glenn Sabin was a 28-year-old newlywed diagnosed with chronic lymphocytic leukemia (CLL)-a disease doctors called "uniformly fatal." Treatments could buy him some time and eventually ease his discomfort, but there was no conventional cure. Glenn's prognosis was clear: he was going to die.

Although Glenn and his wife, Linda, continued to consult with doctors, cancer specialists and top oncologists, Glenn made a monumental decision: he would become his own health advocate. While he continued to "watch and wait," Glenn would figure out how to stay alive.

No one could predict when a large-scale clinical trial would discover a cure for CLL, so Glenn began his own, medically monitored and carefully researched lifestyle changes. He would conduct his own, single patient clinical trial.

He would become an "n of 1."

Today, Glenn is not only alive, but a 2012 biopsy at Harvard confirmed that his bone marrow contains no leukemic cells. His case is now part of the medical literature.

In n of 1, author Glenn Sabin takes readers along his remarkable journey with 'incurable' cancer, where he discovers:

• No two cancers are exactly alike. Our bodies, minds and diseases are unique, and need to be treated as such.
• Knowledge and empowerment are your best allies against a life-limiting diagnosis.
• Lifestyle changes are a powerful way to help prevent, manage and reduce the recurrence of disease--and to improve your quality of life.
• A strong support system and a clear mind may significantly improve your health.

https: //www.glennsabin.com

Twitter: @GlennSabin

LinkedIn: https: //www.linkedin.com/in/glennsabin/

GLENN SABIN lives in the Washington, D.C., area with his wife, Linda, sons Miles and Jared, and his mini schnauzer, Leo. He is the founder of FON Consulting, a strategy and business development firm advancing the future of n-of-1 personalized medicine. A sought-after cancer coach, Sabin writes and speaks extensively on how technology and lifestyle approaches are reshaping the landscape of cancer prevention and personalized care. Connect with Glenn at fonconsulting.com and glennsabin.com.

Dr. Dawn Lemanne, n of 1 co-author with Glenn Sabin, is a practicing oncologist and integrative medicine authority. One of a small but growing number of oncologists integrating conventional and complementary therapies to treat cancer, Dr. Lemanne approaches each patient as an n of 1. Her practice draws patients from around the globe. Dr. Lemanne is a proponent of rigorous single-subject research design development and is active in the quantified self movement. The first medical oncologist to serve on the faculty of New York's Memorial Sloan Kettering Cancer Center's integrative medicine service, she currently teaches physicians in the University of Arizona's flagship integrative medicine fellowship. She is the author of peer-reviewed scientific articles, textbook chapters, and works for the popular press. Dr. Lemanne speaks by invitation domestically and internationally. After earning the MD degree at the University of California, San Francisco, Dr. Lemanne trained in medical oncology at Stanford University and in integrative medicine at the University of Arizona. She also holds advanced degrees from UC Berkeley and Johns Hopkins University. Dr. Lemanne practices at Oregon Integrative Oncology, in Ashland, Oregon. You can learn more about Dr. Lemanne's work at www.oregonio.com.